These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 35750991)

  • 1. Can the administration of platelet lysates to the brain help treat neurological disorders?
    Nebie O; Buée L; Blum D; Burnouf T
    Cell Mol Life Sci; 2022 Jun; 79(7):379. PubMed ID: 35750991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelet lysate biotherapy for traumatic brain injury: preclinical assessment.
    Nebie O; Carvalho K; Barro L; Delila L; Faivre E; Renn TY; Chou ML; Wu YW; Nyam-Erdene A; Chou SY; Buée L; Hu CJ; Peng CW; Devos D; Blum D; Burnouf T
    Brain; 2021 Nov; 144(10):3142-3158. PubMed ID: 34086871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates.
    Nebie O; Devos D; Vingtdeux V; Barro L; Devedjian JC; Jonneaux A; Chou ML; Bordet R; Buée L; Knutson F; Blum D; Burnouf T
    J Biomed Sci; 2019 Oct; 26(1):89. PubMed ID: 31666073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective activity of a virus-safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury models.
    Delila L; Nebie O; Le NTN; Barro L; Chou ML; Wu YW; Watanabe N; Takahara M; Buée L; Blum D; Devos D; Burnouf T
    Bioeng Transl Med; 2023 Jan; 8(1):e10360. PubMed ID: 36684076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.
    Nguyen L; Lucke-Wold BP; Mookerjee S; Kaushal N; Matsumoto RR
    Adv Exp Med Biol; 2017; 964():133-152. PubMed ID: 28315269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease.
    Chou ML; Wu JW; Gouel F; Jonneaux A; Timmerman K; Renn TY; Laloux C; Chang HM; Lin LT; Devedjian JC; Devos D; Burnouf T
    Biomaterials; 2017 Oct; 142():77-89. PubMed ID: 28728000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery.
    Burnouf T; Chou ML; Lundy DJ; Chuang EY; Tseng CL; Goubran H
    J Biomed Sci; 2023 Sep; 30(1):79. PubMed ID: 37704991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
    Veenman L
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease.
    Francardo V; Schmitz Y; Sulzer D; Cenci MA
    Exp Neurol; 2017 Dec; 298(Pt B):137-147. PubMed ID: 28988910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of mushrooms and their biomolecules along with a glimpse of in silico approach in neurodegenerative diseases.
    Rai SN; Mishra D; Singh P; Vamanu E; Singh MP
    Biomed Pharmacother; 2021 May; 137():111377. PubMed ID: 33601145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
    Lauterbach EC; Victoroff J; Coburn KL; Shillcutt SD; Doonan SM; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):8-18. PubMed ID: 20160205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.
    Picciotto MR; Zoli M
    Front Biosci; 2008 Jan; 13():492-504. PubMed ID: 17981563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.
    Salcedo I; Tweedie D; Li Y; Greig NH
    Br J Pharmacol; 2012 Jul; 166(5):1586-99. PubMed ID: 22519295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.
    Chakrabarti M; Haque A; Banik NL; Nagarkatti P; Nagarkatti M; Ray SK
    Brain Res Bull; 2014 Oct; 109():22-31. PubMed ID: 25245209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple beneficial effects of melanocortin MC
    Giuliani D; Ottani A; Neri L; Zaffe D; Grieco P; Jochem J; Cavallini GM; Catania A; Guarini S
    Prog Neurobiol; 2017 Jan; 148():40-56. PubMed ID: 27916623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges.
    Rahman MH; Bajgai J; Fadriquela A; Sharma S; Trinh TT; Akter R; Jeong YJ; Goh SH; Kim CS; Lee KJ
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching Roles: Beneficial Effects of Adipose Tissue-Derived Mesenchymal Stem Cells on Microglia and Their Implication in Neurodegenerative Diseases.
    Sánchez-Castillo AI; Sepúlveda MR; Marín-Teva JL; Cuadros MA; Martín-Oliva D; González-Rey E; Delgado M; Neubrand VE
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
    Kim DS; Choi HI; Wang Y; Luo Y; Hoffer BJ; Greig NH
    Cell Transplant; 2017 Sep; 26(9):1560-1571. PubMed ID: 29113464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.